Search results for "Cost Effectiveness"

showing 10 items of 115 documents

Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haema…

2016

Patients undergoing allogeneic haematopoietic stem cell transplantation (alloHSCT) are at risk of developing invasive fungal infections (IFIs). Even with introduction of oral triazole antifungal agents (fluconazole, itraconazole, posaconazole and voriconazole) IFI-associated morbidity and mortality rates and economic burden remain high. Despite their proven efficacy, it is currently unknown which is the most cost-effective antifungal prophylaxis (AFP) agent. To determine the costs and outcomes associated with AFP, a decision-analytic model was used to simulate treatment in a hypothetical cohort of 1000 patients undergoing alloHSCT from the perspective of the Spanish National Health System. …

Adult0301 basic medicinemedicine.medical_specialtyPosaconazoleAntifungal AgentsCost effectivenessItraconazoleCost-Benefit Analysismedicine.medical_treatment030106 microbiologyDermatologyHematopoietic stem cell transplantationDecision Support Techniques03 medical and health sciencesInternal medicinemedicineHumansFluconazoleVoriconazolebusiness.industryMortality rateHematopoietic Stem Cell TransplantationGeneral MedicineTriazolesSurgeryTransplantationInfectious DiseasesSpainVoriconazoleItraconazolebusinessInvasive Fungal InfectionsFluconazolemedicine.drugMycoses
researchProduct

Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care

2017

Aims: To evaluate the applicability and cost-effectiveness of a clinical risk score (DIABSCORE) to screen for type 2 diabetes in primary care patients. Methods: Multicenter cross-sectional study of 10,508 adult no previously diagnosed with diabetes, in 2 Spanish regions (Canary Islands and Valencian Community). The variables comprising DIABSCORE were age, waist to height ratio, family history of diabetes and gestational diabetes. ROC curves were obtained; the diabetes prevalences odds ratios (HbA1c >= 6.5%) between patients exposed and not exposed to DIABSCORE >= 100, and to fasting blood glucose >= 126 mg/dL were calculated. The opinions of both the professionals and the patients concernin…

AdultBlood Glucosemedicine.medical_specialtyCost effectivenessEndocrinology Diabetes and MetabolismCost-Benefit AnalysisType 2 diabetes030204 cardiovascular system & hematologyValencianCost effectiveness03 medical and health sciences0302 clinical medicineEndocrinologyPregnancyInternal medicineDiabetes mellitusInternal MedicinemedicineOdds RatioPrevalenceHumansMass Screening030212 general & internal medicineFamily historyPrimary health careWaist-to-height ratioClinic epidemiologyPrimary Health Carebusiness.industryType 2 diabetesGeneral MedicineOdds ratioMiddle Agedmedicine.diseaselanguage.human_languageGestational diabetesCross-Sectional StudiesDiabetes Mellitus Type 2ROC CurveSpainEmergency medicinelanguageScreeningFemalebusiness
researchProduct

Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.

2010

Abstract Background Which is the least expensive recall policy for nodules in the cirrhotic liver remains unclear. Aim Aim of the study was to analyze the costs of different recall diagnostic strategies of hepatocellular carcinoma (HCC) on cirrhosis on a real series of patients. Methods 75 consecutive small liver nodules (10–30 mm) detected at conventional ultrasonography in 60 patients with cirrhosis were submitted to contrast-enhanced ultrasound, computed tomography and gadolinium-magnetic resonance imaging with a final diagnosis established according to the latest guidelines which include different strategies for nodules 10–19 mm or ≥20 mm. The actual costs required to fully characterise…

AdultDiagnostic ImagingMalemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularCost effectivenessHCC diagnosismedicineHumansProspective StudiesAgedAged 80 and overHepatologyRecallbusiness.industryNon invasiveUltrasoundLiver NeoplasmsGastroenterologyNodule (medicine)Middle Agedmedicine.diseaseHepatocellular carcinomaCost analysisCosts and Cost AnalysisFemaleRadiologymedicine.symptombusiness
researchProduct

Health science student teachers' perceptions of teacher competence: A qualitative study.

2019

Abstract Background Health science teacher competence is multifaceted and continuously changing according to national and international healthcare standards. Organizational restructuring and emphasis on cost effectiveness is changing the scope of health science teachers' practical work and their role in healthcare (worldwide). Aim This study aimed to describe student teachers' perceptions of the competencies needed to work as an educator in the healthcare field. Objective of study was to gain new knowledge which can be used in the development of teacher education programs in nursing science and to define a broader definition of the health science educators. Methods A qualitative study was c…

AdultMaleCost effectivenessEducation03 medical and health sciences0302 clinical medicineHealth careComputingMilieux_COMPUTERSANDEDUCATIONHumans030212 general & internal medicineStudentsCurriculumCompetence (human resources)Health EducationGeneral NursingFinlandQualitative ResearchMedical education030504 nursingbusiness.industryFocus GroupsMiddle AgedFocus groupFacultyTeacher educationContent analysisFemalePerception0305 other medical sciencebusinessPsychologyQualitative researchNurse education today
researchProduct

Long-term cost-effectiveness of cognitive behavioral therapy versus psychodynamic therapy in social anxiety disorder.

2015

Background To determine the cost-effectiveness of cognitive behavioral therapy (CBT) versus psychodynamic therapy (PDT) in the treatment of social anxiety disorder after a follow-up of 30 months from a societal perspective. Methods This analysis was conducted alongside the multicenter SOPHO-NET trial; adults with a primary diagnosis of social anxiety disorder received CBT (n = 209) or PDT (n = 207). Data on health care utilization and productivity loss were collected at baseline, after 6 months (posttreatment), and three further follow-ups to calculate direct and indirect costs. Anxiety-free days (AFDs) calculated based on remission and response were used as measure of effect. The increment…

AdultMaleCost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisTime03 medical and health sciencesIndirect costs0302 clinical medicineWillingness to paymedicineHumanshealth care economics and organizationsPsychodynamic psychotherapyCost–benefit analysisCognitive Behavioral TherapySocial anxietyPhobia Social3. Good health030227 psychiatryCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeCognitive therapyFemalePsychologyPsychotherapy Psychodynamic030217 neurology & neurosurgeryClinical psychologyDepression and anxiety
researchProduct

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

2011

Background: Heptavalent pneumococcal conjugate vaccine (PCV-7) was licensed to provide immunity against pneumococcal disease caused by seven serotypes of S. pneumoniae. Thirteen-valent pneumococcal conjugate vaccine (PCV-13) includes 6 additional serotypes for preventing invasive pneumococcal disease. Objective: The objective of this study was to estimate the potential health benefits, costs, and cost-effectiveness of vaccination with PCV-13 in the Community of Valencia and to generate valuable information for policy makers at regional and country levels. Methods: A decision tree was designed to determine the health and economic outcomes in hypothetical cohorts of vaccinated and unvaccinate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCost effectivenessPharmacoeconomic assessmentCost-Benefit AnalysisPneumococcal conjugate vaccinePneumococcal InfectionsHerd immunityPneumococcal VaccinesIndirect costsYoung AdultEnvironmental healthmedicineHeptavalent Pneumococcal Conjugate VaccineHumansChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPneumococcal conjugate vaccineVaccinationPublic Health Environmental and Occupational HealthInfant NewbornInfantMiddle AgedQuality-adjusted life yearVaccinationInfectious DiseasesSpainChild PreschoolCohortMolecular MedicineCost-effectivenessFemalebusinessmedicine.drugVaccine
researchProduct

Specific allergen immunotherapy for the treatment of allergic asthma: a review of current evidence.

2017

Asthma is frequently associated with atopy, characterized by the production of specific immunoglobulin E in response to environmental allergens. Currently, two types of allergen immunotherapy (AIT) are used in clinical practice: subcutaneous and sublingual immunotherapy, both accepted as key components of the therapeutic repertoire for allergic rhinitis and conjunctivitis. However, their role in asthma remains controversial. The present document is aimed at providing the clinicians with a review of the evidence on the use of AIT in asthma, focusing on the most relevant aspects of its mechanism of action, its efficacy, and existing data on safety, tolerability, and cost-effectivity, both in …

AdultMaleSevere asthmaAllergyAllergen immunotherapymedicine.medical_specialtyEfficacyCost-effectiveness.Cost effectivenessImmunologyMEDLINEAtopy03 medical and health sciences0302 clinical medicineHypersensitivityAdultsImmunology and AllergyMedicineHumansIntensive care medicineChildChildrenAllergen immunotherapyAsthmabusiness.industryAsthma treatmentAllergensmedicine.diseaseAsthmaClinical trialSystematic review030228 respiratory systemDesensitization ImmunologicSLIT030220 oncology & carcinogenesisImmunologyFemaleSafetySCITbusinessJournal of investigational allergologyclinical immunology
researchProduct

Telemonitoring of Crohn's Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis.

2019

Background Although electronic health interventions are considered safe and efficient, evidence regarding the cost-effectiveness of telemonitoring in inflammatory bowel disease is lacking. Objective We aimed to evaluate the cost-effectiveness and cost-utility of the Telemonitorización de la Enfermedad de Crohn y Colitis Ulcerosa (Telemonitoring of Crohn’s Disease and Ulcerative Colitis [TECCU]) Web platform (G_TECCU intervention group) for telemonitoring complex inflammatory bowel disease, compared with standard care (G_control) and nurse-assisted telephone care (G_NT intervention group). Methods We analyzed cost-effectiveness from a societal perspective by comparing the 3 follow-up method…

AdultMalemedicine.medical_specialty020205 medical informaticsCost effectivenessCost-Benefit AnalysisPsychological interventionHealth Informatics02 engineering and technologylcsh:Computer applications to medicine. Medical informaticsInflammatory bowel diseaseinflammatory bowel diseaseslaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled triallawInternal medicineHealth care0202 electrical engineering electronic engineering information engineeringmedicineHumanscost-effectivenessCrohn's diseaseOriginal Papercolitis ulcerativebusiness.industrylcsh:Public aspects of medicineCrohn diseaselcsh:RA1-1270Cost-effectiveness analysisMiddle Agedmedicine.diseaseUlcerative colitisTelemedicinelcsh:R858-859.7030211 gastroenterology & hepatologyFemaleeHealthbusinessJournal of medical Internet research
researchProduct

Efficacy and cost-effectiveness of a blended cognitive behavioral therapy for depression in Spanish primary health care:Study protocol for a randomis…

2018

Background: Data from primary health care in Spain show a high prevalence of the major depressive disorder. Blended treatment (combination of face-to-face and online components) seems to be a very promising tool for the optimization and dissemination of psychological treatments in a cost-effective form. Although there is growing data that confirm the advantages of blended therapies, few studies have analyzed their application in regular clinical practice. The objective of the present paper is to describe the protocol for a clinical study aimed at exploring the clinical and cost-effectiveness of a blended cognitive behavioral therapy (b-CBT) for depression, compared to treatment as usual (TA…

AdultMalemedicine.medical_specialtyAdolescentlcsh:RC435-571Cost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisInternet-based treatmentEquivalence Trials as TopicRandomised non-inferiority trial03 medical and health sciencesStudy ProtocolYoung Adult0302 clinical medicinePatient satisfactionQuality of life (healthcare)SDG 3 - Good Health and Well-beinglcsh:PsychiatrymedicineHumans030212 general & internal medicineYoung adultBlended treatmentDepression (differential diagnoses)Randomized Controlled Trials as TopicPrimary health careCognitive Behavioral TherapyPrimary Health Carebusiness.industryDepressionRepeated measures designProfessional-Patient Relationsmedicine.disease3. Good health030227 psychiatryCognitive behavioral therapyCognitive behavioral therapyPsychiatry and Mental healthTreatment OutcomePatient SatisfactionSpainPhysical therapyQuality of LifeMajor depressive disorder/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalebusiness
researchProduct

Refined atrial fibrillation screening and cost-effectiveness in the German population

2021

ObjectiveLittle is known on optimal screening population for detecting new atrial fibrillation (AF) in the community. We describe characteristics and estimate cost-effectiveness for a single timepoint electrocardiographic screening.MethodsWe performed a 12-lead ECG in the German population-based Gutenberg Health Study between 2007 and 2012 (n=15 010), mean age 55±11 years, 51% men and collected more than 120 clinical and biomarker variables, including N-terminal pro B-type natriuretic peptide (Nt-proBNP), risk factors, disease symptoms and echocardiographic variables.ResultsOf 15 010 individuals, 466 (3.1%) had AF. New AF was found in 32 individuals, 0.2% of the total sample, 0.5% of indivi…

AdultMalemedicine.medical_specialtyCost effectivenessCost-Benefit AnalysisPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationNatriuretic Peptide BrainEpidemiologyHumansMedicine030212 general & internal medicineRisk factoreducationStrokeAgedHeart Failureeducation.field_of_studybusiness.industryAtrial fibrillationMiddle Agedmedicine.diseasePeptide Fragments3. Good healthStrokeHeart failureBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersHeart
researchProduct